Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy Andrej TraunerSonia BorrellSebastien Gagneux Current Opinion Open access 25 June 2014 Pages: 1063 - 1072
Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD? Clémence MartinJustine Frija-MassonPierre-Régis Burgel Leading Article 03 June 2014 Pages: 1073 - 1089
Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs James Cheng-Chung Wei Leading Article 27 June 2014 Pages: 1091 - 1096
Aripiprazole (ABILIFY MAINTENA®): A Review of Its Use as Maintenance Treatment for Adult Patients with Schizophrenia Matt ShirleyCaroline M. Perry Adis Drug Evaluation 27 June 2014 Pages: 1097 - 1110
Pazopanib: A Review of Its Use in the Management of Advanced Renal Cell Carcinoma Paul L. McCormack Adis Drug Evaluation 17 June 2014 Pages: 1111 - 1125
Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C Gillian M. Keating Adis Drug Evaluation 24 June 2014 Pages: 1127 - 1146
Siltuximab: First Global Approval Anthony MarkhamTrina Patel R&D Insight Report 24 June 2014 Pages: 1147 - 1152
Vorapaxar: First Global Approval Raewyn M. PooleShelley Elkinson R&D Insight Report 25 June 2014 Pages: 1153 - 1163